Searched for
PFIZER OMICRON
Covid omicron vaccinations approved by FDA for use in infants as young as 6 monthsThe FDA is urging people to be up to date with all vaccines. Now children as young as 6 months old can get the new Omicron booster dose.- Moderna seeks US FDA approval for Omicron Covid booster for children over 6 yearsIn a request to the Food and Drug Administration (FDA), Boston-based biotech has requested that omicron shots be approved for teenagers age...
- Pfizer, BioNTech begin vaccine trial to target new strainThe study will have 1,420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech Covid vaccine or an Omic...
- Pfizer-BioNTech begin trials of new vaccine against Omicron variantThe study will have 1420 subjects, with three cohorts examining different regimens of the current Pfizer-BioNTech COVID vaccine or an Omicr...
- Pfizer-BioNTech begin Omicron vaccine trialPfizer's CEO Albert Bourla has previously said that the pharmaceutical giant could be ready to file for regulatory approval of the shot by ...
- Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: StudyThe study was conducted at the Italian Spallanzani Institute on comparable groups of sera from individuals vaccinated with Sputnik V and Pf...
- Sputnik V protects two times more against Covid than Pfizer's vaccine: StudySputnik V in a statement on Thursday said that as per an independent comparative study conducted by the Spallanzani institute in Italy, its...
- Pfizer expects Omicron vaccine to be ready in MarchA vaccine focused directly on the Omicron variant would also guard against breakthrough infections of a strain that has proven highly conta...
- US FDA backs Pfizer's COVID-19 booster shot for 12- to 15-year-oldsThe regulatory decisions come as COVID-19 cases surge due to the Omicron variant, with health authorities warning that its high transmissib...
- Omicron variant resistant to antibodies, two vaccine doses: StudyHowever, the study found that a third dose of the Pfizer vaccine, and mixing Pfizer and AstraZeneca preventives may protect well against th...
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...
- China's Sinovac COVID-19 booster weaker against Omicron: Hong Kong StudySinovac's CoronaVac and state-owned Sinopharm's BBIBP-CorV vaccine are the two most-used vaccines in China.
- Pfizer pill becomes 1st US-authorized home COVID treatmentData from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in pati...
- J&J, Sinopharm, Sputnik V COVID-19 shots less effective against Omicron -studyVaccines from Moderna, AstraZeneca, Pfizer and partner BioNTech retained activity against Omicron, but the antibody response was greatly re...
- Pfizer confirms COVID pill's results, potency versus omicronThe Food and Drug Administration is expected to soon rule on whether to authorize Pfizer's pill and a competing pill from Merck, which was ...
- Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
- Pfizer jab gives 70% protection against hospitalisation during Omicron: StudySouth African scientists have so far confirmed around 550 Omicron sequences, with the variant accounting for 78% of sequences from November...
- BioNTech, Pfizer say test shows 3 doses of vaccine neutralise OmicronBioNTech and Pfizer said on Wednesday a three-shot course of their COVID-19 vaccine was shown to generate a neutralising effect against the...
- Pfizer Covid vaccine provides partial protection against Omicron: StudyThe Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that sugg...
- Pfizer working on updated jab in response to Omicron variant: CEOPfizer's chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a "very ...
Load More
